Unlearn
Phase 1/2Discover how Unlearn uses AI to create digital twins of clinical trial participants, streamlining clinical development and enabling confident decision-making.
Founded
2017
Focus
AI / Machine Learning
About
Discover how Unlearn uses AI to create digital twins of clinical trial participants, streamlining clinical development and enabling confident decision-making.
Funding History
3Total raised: $66.5M
Series B$50MInsight PartnersSep 15, 2022
Series A$12MDCVCOct 15, 2020
Seed$4.5M8VCJun 15, 2018
Company Info
TypePrivate
Founded2017
LocationSan Francisco, United States
StagePhase 1/2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile